These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 3874147

  • 1. The modulation of immune complex aggregation by classical pathway-mediated reactions.
    Gronski P, Bodenbender L, Kanzy EJ, Loos M, Seiler FR.
    Immunobiology; 1985 May; 169(4):346-61. PubMed ID: 3874147
    [Abstract] [Full Text] [Related]

  • 2. The influence of classical pathway components during alternative pathway--modulated immune complex aggregation: the role of C1 INH.
    Gronski P, Bodenbender L, Kanzy EJ, Seiler FR.
    Behring Inst Mitt; 1984 Nov; (76):29-41. PubMed ID: 6335396
    [Abstract] [Full Text] [Related]

  • 3. Prevention of immune precipitation by purified classical pathway complement components.
    Naama JK, Hamilton AO, Yeung-Laiwah AC, Whaley K.
    Clin Exp Immunol; 1984 Nov; 58(2):486-92. PubMed ID: 6333948
    [Abstract] [Full Text] [Related]

  • 4. Regulation of immune complex-mediated complement activation by autoantibodies (F-42) isolated from sera of patients with systemic lupus erythematosus.
    Daha MR, Hazevoet HM, Vanes LA.
    Clin Exp Immunol; 1983 Sep; 53(3):541-6. PubMed ID: 6604604
    [Abstract] [Full Text] [Related]

  • 5. Activation of the first component of human complement, C1, by monoclonal antibodies directed against different domains of subcomponent C1q.
    Kilchherr E, Schumaker VN, Phillips ML, Curtiss LK.
    J Immunol; 1986 Jul 01; 137(1):255-62. PubMed ID: 3486914
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of immune precipitation by complement.
    Hong K, Takata Y, Sayama K, Kozono H, Takeda J, Nakano Y, Kinoshita T, Inoue K.
    J Immunol; 1984 Sep 01; 133(3):1464-70. PubMed ID: 6747294
    [Abstract] [Full Text] [Related]

  • 7. Activation of the first component of complement, C1, by a monoclonal antibody recognizing the C chain of C1q.
    Heinz HP, Burger R, Golan MD, Loos M.
    J Immunol; 1984 Feb 01; 132(2):804-8. PubMed ID: 6606678
    [Abstract] [Full Text] [Related]

  • 8. Complement-mediated inhibition of immune precipitation. I. Role of the classical and alternative pathways.
    Schifferli JA, Woo P, Peters DK.
    Clin Exp Immunol; 1982 Mar 01; 47(3):555-62. PubMed ID: 6979442
    [Abstract] [Full Text] [Related]

  • 9. C1- inactivator: its efficiency as a regulator of classical complement pathway activation by soluble IgG aggregates.
    Doekes G, van Es LA, Daha MR.
    Immunology; 1983 Jun 01; 49(2):215-22. PubMed ID: 6852866
    [Abstract] [Full Text] [Related]

  • 10. The role of C1, C1-inactivator and C4 in modulating immune precipitation.
    Schifferli JA, Steiger G, Schapira M.
    Clin Exp Immunol; 1985 Jun 01; 60(3):605-12. PubMed ID: 4017288
    [Abstract] [Full Text] [Related]

  • 11. Antibody-independent activation of C1. II. Evidence for two classes of nonimmune activators of the classical pathway of complement.
    Peitsch MC, Kovacsovics TJ, Tschopp J, Isliker H.
    J Immunol; 1987 Mar 15; 138(6):1871-6. PubMed ID: 3029223
    [Abstract] [Full Text] [Related]

  • 12. Control of C1 activation by nascent C3b and C4b: a mechanism of feedback inhibition.
    Ziccardi RJ.
    J Immunol; 1986 May 01; 136(9):3378-83. PubMed ID: 3485688
    [Abstract] [Full Text] [Related]

  • 13. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
    Brown EJ, Ramsey J, Hammer CH, Frank MM.
    J Immunol; 1983 Jul 01; 131(1):403-8. PubMed ID: 6602833
    [Abstract] [Full Text] [Related]

  • 14. Complement activation and impaired capacity to solubilize immune complexes or to prevent their formation in essential mixed cryoglobulinemia.
    Corvetta A, Spaeth PJ, Ghirelli PA, Orecchioni F, Buetler R, Montroni M, Nydegger UE.
    Diagn Immunol; 1983 Jul 01; 1(4):315-23. PubMed ID: 6333960
    [Abstract] [Full Text] [Related]

  • 15. Control of immune complexes by the classical pathway.
    Whaley K, Ahmed AE.
    Behring Inst Mitt; 1989 Jul 01; (84):111-20. PubMed ID: 2529842
    [Abstract] [Full Text] [Related]

  • 16. Monoclonal antibodies against components of the classical pathway of complement.
    Heinz HP, Loos M.
    Complement Inflamm; 1989 Jul 01; 6(3):166-74. PubMed ID: 2472920
    [Abstract] [Full Text] [Related]

  • 17. FN-C1q and C1 INH C1r-C1s complexes as indicators of complement activation in patients with chronic lymphocytic leukaemia.
    Hidvégi T, Ermolin GA, Efremov EE, Dikov MM, Kurmanova LV, Vnashenkova GV, Merkulova MV, Kókai M, Panya A, Füst G.
    Immunol Lett; 1989 Jul 01; 22(1):1-6. PubMed ID: 2550362
    [Abstract] [Full Text] [Related]

  • 18. The functional inhibition of activated C1 inhibitor in normal human serum causes spontaneous consumption of the complement components C2, C3, C4, and factor B.
    Gronski P, Bodenbender L, Kanzy EJ, Piepenbrock M, Seiler FR.
    Immunobiology; 1986 Apr 01; 171(3):252-62. PubMed ID: 3011651
    [Abstract] [Full Text] [Related]

  • 19. Characterization of C1q by monoclonal antibodies.
    Heinz HP, Loos M.
    Behring Inst Mitt; 1984 Nov 01; (76):42-58. PubMed ID: 6335397
    [Abstract] [Full Text] [Related]

  • 20. [Complement components, whole complement activity, and circulating immune complexes in neoplastic diseases].
    Takada K, Morishita M, Sugiura T, Suzuki M, Torii Y, Ichimura K, Hashigami H, Toshikawa K, Ina Y, Yamamoto M, Oyama A, Urata A.
    Gan No Rinsho; 1983 Apr 01; 29(4):A-19, 293-6. PubMed ID: 6602233
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.